ExodusPoint Capital Management’s ACELYRIN SLRN Stock Holding History

ExodusPoint Capital Management’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-134,680	Closed	-$423K	–	1956
2024 Q4	$423K	Buy	+134,680	New	+$652K	﹤0.01%	1194
2024 Q3	–	Sell	-189,578	Closed	-$836K	–	2056
2024 Q2	$836K	Buy	189,578 +149,197	+369%	+$699K	0.01%	1083
2024 Q1	$273K	Buy	+40,381	New	+$307K	﹤0.01%	1280
2023 Q3	–	Sell	-111,077	Closed	-$2.32M	–	2109
2023 Q2	$2.32M	Buy	+111,077	New	+$2.27M	0.02%	750

Other funds holding SLRN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

ACMC

AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

ExodusPoint Capital Management's SLRN Position: Q1 2025 in Review

ExodusPoint Capital Management sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 134,680 shares — an estimated $423K sold.

ExodusPoint Capital Management first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $2.32M in Q2 2023. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

ExodusPoint Capital Management reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 134,680 ACELYRIN shares in Q1 2025, an estimated $423K.
ExodusPoint Capital Management first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
ExodusPoint Capital Management's ACELYRIN position peaked at $2.32M in Q2 2023.
105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.